Infections involving multi-drug resistant bacteria are a major concern. Colistin is used as the "last-resort antibiotic" for dreaded
multidrug-resistant pathogens, especially in hospitals. However, gut
bacteria that have become insensitive to colistin now exist - owing to
the mobile resistance gene mcr-1.
In early 2016, bacteria carrying this resistance gene were detected in Germany for the first time. Since then, there has been growing concern that it may develop into a "superbug" against which even emergency antibiotics are no longer effective.
The risk of a further spread of this colistin resistance is high because it takes place through so-called mobile genetic elements (plasmids) which are transferred between different types of bacteria relatively easily.
Together with her colleagues from Giessen University and scientists from the research association RESET, she tested a rapid genotypic resistance test for colistin that is already commercially available.
"This is the only way with which mobile resistance can be differentiated from common resistance, because phenotypically they are the same," explains Can Imirzalioglu, who is also first author of the study and DZIF scientist at the Giessen University.
Getting results rapidly
For the evaluation of this rapid test, the scientists worked together with the company AmplexBiosystems GmbH which provided the testing kits free of charge. 104 bacterial isolates from animals, humans and the environment underwent testing with the molecular rapid test: the rapid test results were compared to those from complete genome sequencing or PCR, and demonstrated 100% sensitivity and specificity.
The test could clearly differentiate between common colistin resistance and mobile resistance located on plasmids. "The test results become available in only twenty minutes," explains Judith Schmiedel from the Giessen Team. "With the conventional procedure, it takes several hours to get results.
Additionally, the system is very uncomplicated, so it should be developed further for future use in hospitals as well as for livestock farming and food production." However, the rapid test is still limited because applying it directly to samples has not yet been evaluated. Up to now, the test has been only applied to bacterial cultures, but the scientists are certain that it is only a matter of time before it is developed further.